During the past decade, Alabama Neurology Associates conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alabama Neurology Associates" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Alabama Neurology Associates, PC" with 1 trials sponsored, "IMS HEALTH GmbH & Co. OHG" with 1 trials sponsored and "Mallinckrodt" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Neurology Associates" #1 collaborator was "Biogen" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Neurology Associates" are "Multiple Sclerosis" (3 trials), "Idiopathic Parkinson Disease" (1 trials), "Multiple Sclerosis (MS)" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Alabama Neurology Associates" in a lesser frequency.

Most popular intervention types in "Alabama Neurology Associates" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials), "Methylprednisolone" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Neurology Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Alabama Neurology Associates". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Alabama Neurology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Neurology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".